Your session is about to expire
← Back to Search
Exparel Injection for Postoperative Pain
Study Summary
This trial will compare the postoperative pain control of Exparel (a bupivacaine liposomal injectable suspension) to that of plain bupivacaine in patients who have had surgery to remove their eye.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am 18 years old or older.I am having my eye removed at Mayo Clinic Rochester by the Ophthalmology Department.I am not pregnant or nursing.
- Group 1: Plain bupivacaine
- Group 2: Exparel (sustained release bupivacaine)
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What functions is Bupivacaine commonly employed for?
"Bupivacaine can be utilized to address conditions such as pemphigus, acute nonspecific tenosynovitis, and general anesthesia."
What is the aggregate count of participants in this trial?
"Affirmative, clinicaltrials.gov confirms that this medical trial is open for recruitment and was made available on February 1st 2015. It has been updated most recently on March 11th 2022 and 70 individuals are needed from a single site to complete the study."
Could you provide examples of other research studies on Bupivacaine?
"At present, 109 studies are being conducted on Bupivacaine with 18 at Phase 3. Interestingly, while Philadelphia has a number of trials studying this drug, there is an expansive network of 144 medical sites administering the medication across the globe."
Has the Food and Drug Administration (FDA) sanctioned Bupivacaine for use?
"The safety of Bupivacaine is rated at a 3, as this treatment has already been approved and can be found in Phase 4 trials."
Are there any open slots to participate in this clinical experiment?
"Affirmative. According to clinicaltrials.gov, this scientific investigation is actively recruiting participants, with the initial post dating back to February 1st 2015 and most recent update occurring on March 11th 2022. 70 volunteers are required from a single centre for completion of the trial."
Share this study with friends
Copy Link
Messenger